Published in J Virol on February 15, 2012
Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J Virol (2013) 1.39
Breast milk oligosaccharides: structure-function relationships in the neonate. Annu Rev Nutr (2014) 1.19
Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens. J Virol (2012) 1.18
Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis (2014) 1.16
Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children. J Clin Microbiol (2014) 1.15
The sweet spot: defining virus-sialic acid interactions. Nat Rev Microbiol (2014) 1.13
Human milk glycomics and gut microbial genomics in infant feces show a correlation between human milk oligosaccharides and gut microbiota: a proof-of-concept study. J Proteome Res (2014) 1.12
Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis. Clin Infect Dis (2015) 0.97
Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses. Mol Cell Proteomics (2014) 0.97
The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol (2013) 0.97
Interactions among capsid proteins orchestrate rotavirus particle functions. Curr Opin Virol (2012) 0.94
Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol (2014) 0.93
Gangliosides have a functional role during rotavirus cell entry. J Virol (2012) 0.92
Poly-LacNAc as an age-specific ligand for rotavirus P[11] in neonates and infants. PLoS One (2013) 0.91
The spike protein VP4 defines the endocytic pathway used by rotavirus to enter MA104 cells. J Virol (2012) 0.91
Rotaviruses reach late endosomes and require the cation-dependent mannose-6-phosphate receptor and the activity of cathepsin proteases to enter the cell. J Virol (2014) 0.88
Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev (2015) 0.88
Both α2,3- and α2,6-linked sialic acids on O-linked glycoproteins act as functional receptors for porcine Sapovirus. PLoS Pathog (2014) 0.87
Genome-wide RNAi screen reveals a role for the ESCRT complex in rotavirus cell entry. Proc Natl Acad Sci U S A (2013) 0.86
Structural basis of glycan interaction in gastroenteric viral pathogens. Curr Opin Virol (2014) 0.85
Investigating virus-glycan interactions using glycan microarrays. Curr Opin Virol (2014) 0.83
Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun (2015) 0.82
Rotavirus P[8] Infections in Persons with Secretor and Nonsecretor Phenotypes, Tunisia. Emerg Infect Dis (2015) 0.81
Porcine Sapelovirus Uses α2,3-Linked Sialic Acid on GD1a Ganglioside as a Receptor. J Virol (2016) 0.79
Complete genome characterization of recent and ancient Belgian pig group A rotaviruses and assessment of their evolutionary relationship with human rotaviruses. J Virol (2014) 0.79
Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection. J Virol (2014) 0.79
Binding Patterns of Rotavirus Genotypes P[4], P[6], and P[8] in China with Histo-Blood Group Antigens. PLoS One (2015) 0.79
Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Sci Rep (2016) 0.78
Genetic diversity of porcine group A rotavirus strains in the UK. Vet Microbiol (2014) 0.78
Porcine Rotaviruses: Epidemiology, Immune Responses and Control Strategies. Viruses (2017) 0.78
Inflammatory and oxidative stress in rotavirus infection. World J Virol (2016) 0.76
A genome-wide association meta-analysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways. Hum Mol Genet (2016) 0.76
A dual chicken IgY against rotavirus and norovirus. Antiviral Res (2012) 0.76
Glycan Specificity of P[19] Rotavirus and Comparison with Those of Related P Genotypes. J Virol (2016) 0.75
Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol (2016) 0.75
Functional and Structural Characterization of P[19] Rotavirus VP8* Interaction with Histo-blood Group Antigens. J Virol (2016) 0.75
P[8] and P[4] Rotavirus Infection Associated with Secretor Phenotypes Among Children in South China. Sci Rep (2016) 0.75
Evidences and consequences of extra-intestinal spread of rotaviruses in humans and animals. Virusdisease (2014) 0.75
An examination of co-infection in acute gastroenteritis and histo-blood group antigens leading to viral infection susceptibility. Biomed Rep (2016) 0.75
Porcine Milk Oligosaccharides and Sialic Acid Concentrations Vary Throughout Lactation. Front Nutr (2016) 0.75
Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol (2004) 5.20
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis (2003) 4.03
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol (2004) 2.68
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol (2005) 2.29
ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie (2001) 2.23
Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol (1991) 1.99
Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta (1999) 1.96
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92
ABH and related histo-blood group antigens; immunochemical differences in carrier isotypes and their distribution. Vox Sang (1989) 1.91
Mendelian resistance to human norovirus infections. Semin Immunol (2006) 1.77
Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol (1999) 1.73
Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol (2011) 1.73
Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells. J Virol (2000) 1.72
Epidemiology of rotavirus serotypes in Melbourne, Australia, from 1973 to 1989. J Clin Microbiol (1991) 1.72
Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology (1989) 1.71
Temporal and geographical distributions of human rotavirus serotypes, 1983 to 1988. J Clin Microbiol (1989) 1.67
Ganglioside-linked terminal sialic acid moieties on murine macrophages function as attachment receptors for murine noroviruses. J Virol (2009) 1.61
Sialic acid glycoproteins inhibit in vitro and in vivo replication of rotaviruses. J Clin Invest (1987) 1.61
Both surface proteins (VP4 and VP7) of an asymptomatic neonatal rotavirus strain (I321) have high levels of sequence identity with the homologous proteins of a serotype 10 bovine rotavirus. Virology (1993) 1.58
Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci U S A (2000) 1.56
Integrin-using rotaviruses bind alpha2beta1 integrin alpha2 I domain via VP4 DGE sequence and recognize alphaXbeta2 and alphaVbeta3 by using VP7 during cell entry. J Virol (2003) 1.56
Rotavirus proteins VP7, NS28, and VP4 form oligomeric structures. J Virol (1990) 1.52
Binding to sialic acids is not an essential step for the entry of animal rotaviruses to epithelial cells in culture. J Virol (1993) 1.50
C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol (2006) 1.45
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol (2010) 1.39
Two modes of human rotavirus entry into MA 104 cells. Arch Virol (1985) 1.37
Insight into host cell carbohydrate-recognition by human and porcine rotavirus from crystal structures of the virion spike associated carbohydrate-binding domain (VP8*). J Mol Biol (2007) 1.36
Human noroviruses recognize sialyl Lewis x neoglycoprotein. Glycobiology (2008) 1.35
Lewis histo-blood group system and associated secretory phenotypes. Vox Sang (1995) 1.35
Sialic acid dependence in rotavirus host cell invasion. Nat Chem Biol (2008) 1.31
Role of sialic acids in rotavirus infection. Glycoconj J (2006) 1.28
Alpha2,6-linked sialic acid acts as a receptor for Feline calicivirus. J Gen Virol (2007) 1.25
Entry of rotaviruses is a multistep process. Virology (1999) 1.25
Rotavirus strain types circulating in Africa: Review of studies published during 1997-2006. J Infect Dis (2010) 1.21
High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16
Integrin alpha2beta1 mediates the cell attachment of the rotavirus neuraminidase-resistant variant nar3. Virology (2000) 1.16
Further investigation on the mode of entry of human rotavirus into cells. Arch Virol (1986) 1.14
Human milk contains elements that block binding of noroviruses to human histo-blood group antigens in saliva. J Infect Dis (2004) 1.10
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology (1995) 1.09
Genetic variability of human rotavirus strains isolated from Eastern and Northern India. J Med Virol (2004) 1.08
Histo-blood group antigen and human milk oligosaccharides: genetic polymorphism and risk of infectious diseases. Adv Exp Med Biol (2004) 1.07
Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis (2005) 1.06
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4. J Virol (1993) 0.99
Molecular biology of rotavirus cell entry. Arch Med Res (2002) 0.98
SA11 rotavirus is specifically inhibited by an acetylated sialic acid. J Infect Dis (1990) 0.98
The carbohydrate moiety and high molecular weight carrier of histo-blood group antigens are both required for norovirus-receptor recognition. Glycoconj J (2009) 0.95
Report of the Australian Rotavirus Surveillance Program, 2000/2001. Commun Dis Intell Q Rep (2001) 0.94
Changing pattern of rotavirus G genotype distribution in Chiang Mai, Thailand from 2002 to 2004: decline of G9 and reemergence of G1 and G2. J Med Virol (2007) 0.93
Molecular epidemiology of group A rotavirus in Buenos Aires, Argentina 2004-2007: reemergence of G2P[4] and emergence of G9P[8] strains. J Med Virol (2010) 0.92
Report of the Australian Rotavirus Surveillance Program, 2001/2002. Commun Dis Intell Q Rep (2002) 0.92
Neonatal rotavirus infection in Belém, northern Brazil: nosocomial transmission of a P[6] G2 strain. J Med Virol (2002) 0.91
Rotavirus RRV associates with lipid membrane microdomains during cell entry. Virology (2004) 0.90
Review of rotavirus studies in Africa: 1976-2006. J Infect Dis (2010) 0.89
Children with the Le(a+b-) blood group have increased susceptibility to diarrhea caused by enterotoxigenic Escherichia coli expressing colonization factor I group fimbriae. Infect Immun (2009) 0.87
Review: phenotyping for Lewis and secretor histo-blood group antigens. Immunohematology (1996) 0.85
Temporal distribution of rotavirus G-serotypes in the West Midlands region of the United Kingdom, 1983-1994. J Diarrhoeal Dis Res (1995) 0.85
Annual report of the Rotavirus Surveillance Programme, 1999/2000. Commun Dis Intell (2000) 0.83
Characterization and molecular epidemiology of rotavirus strains recovered in Northern Pretoria, South Africa during 2003-2006. J Infect Dis (2010) 0.81
G and P genotyping of human rotavirus isolated in a university hospital in Korea: implications for nosocomial infections. J Korean Med Sci (2006) 0.81
Characterization of neuraminidase-resistant mutants derived from rotavirus porcine strain OSU. J Virol (2005) 0.79
Elucidating the cell entry mechanisms of porcine rotaviruses. Adv Exp Med Biol (1997) 0.77
Rotavirus vaccine efficacy in African and Asian countries. Lancet (2010) 0.77
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. Cancer Cell (2004) 10.89
Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell (2004) 4.17
Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology (2002) 4.13
Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis (2003) 4.03
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol (2011) 3.95
A test of climate, sun, and culture relationships from an 1810-year Chinese cave record. Science (2008) 3.94
Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J Virol (2005) 3.74
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila) (2009) 3.70
Structural basis for the recognition of blood group trisaccharides by norovirus. J Virol (2007) 3.58
Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab (2006) 3.57
Structures of the bacterial ribosome in classical and hybrid states of tRNA binding. Science (2011) 3.14
Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol (2005) 3.00
New variant of porcine epidemic diarrhea virus, United States, 2014. Emerg Infect Dis (2014) 2.99
MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem (2010) 2.85
Mutations within the P2 domain of norovirus capsid affect binding to human histo-blood group antigens: evidence for a binding pocket. J Virol (2003) 2.82
The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors. J Virol (2004) 2.68
The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J Virol (2005) 2.29
Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Clin Cancer Res (2004) 2.28
Characterization of a rhesus monkey calicivirus representing a new genus of Caliciviridae. J Virol (2008) 2.24
Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants. J Pediatr (2004) 2.20
Detection and genetic characterization of deltacoronavirus in pigs, Ohio, USA, 2014. Emerg Infect Dis (2014) 2.08
Norovirus gastroenteritis, carbohydrate receptors, and animal models. PLoS Pathog (2010) 2.02
Gastroenteritis in US Marines during Operation Iraqi Freedom. Clin Infect Dis (2005) 1.86
Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr (2005) 1.84
Structural basis for the receptor binding specificity of Norwalk virus. J Virol (2008) 1.82
Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection. J Med Virol (2008) 1.81
DICCCOL: dense individualized and common connectivity-based cortical landmarks. Cereb Cortex (2012) 1.78
Effect of combined laser acupuncture on knee osteoarthritis: a pilot study. Lasers Med Sci (2008) 1.77
Noroviral P particle: structure, function and applications in virus-host interaction. Virology (2008) 1.75
Norovirus-host interaction: multi-selections by human histo-blood group antigens. Trends Microbiol (2011) 1.73
E. coli-expressed recombinant norovirus capsid proteins maintain authentic antigenicity and receptor binding capability. J Med Virol (2004) 1.64
Prevalence and genetic characterization of caliciviruses among children hospitalized for acute gastroenteritis in the United States. Infect Genet Evol (2004) 1.62
Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone (2008) 1.59
Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology (2002) 1.58
Norovirus-host interaction: implications for disease control and prevention. Expert Rev Mol Med (2007) 1.57
MicroRNA-driven developmental remodeling in the brain distinguishes humans from other primates. PLoS Biol (2011) 1.57
Widespread expression of piRNA-like molecules in somatic tissues. Nucleic Acids Res (2011) 1.56
Elucidation of strain-specific interaction of a GII-4 norovirus with HBGA receptors by site-directed mutagenesis study. Virology (2008) 1.54
Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer (2010) 1.50
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun (2012) 1.49
Genetic and phenotypic characterization of GII-4 noroviruses that circulated during 1987 to 2008. J Virol (2010) 1.46
C-terminal arginine cluster is essential for receptor binding of norovirus capsid protein. J Virol (2006) 1.45
In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells (2012) 1.44
Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) (2007) 1.44
Porcine coronavirus HKU15 detected in 9 US states, 2014. Emerg Infect Dis (2014) 1.43
Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution. PLoS One (2009) 1.42
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrob Agents Chemother (2004) 1.41
Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J Clin Microbiol (2002) 1.40
Seroprevalence of noroviruses in swine. J Clin Microbiol (2005) 1.39
Correlated conformational events in EF-G and the ribosome regulate translocation. Nat Struct Mol Biol (2010) 1.39
Norovirus P particle, a novel platform for vaccine development and antibody production. J Virol (2010) 1.39
N'-[1-(2-Hydroxy-phen-yl)ethyl-idene]-2-nitro-benzohydrazide methanol solvate. Acta Crystallogr Sect E Struct Rep Online (2009) 1.39
Rapid immune recovery and graft-versus-host disease-like engraftment syndrome following adoptive transfer of Costimulated autologous T cells. Clin Cancer Res (2009) 1.38
Predicting susceptibility to norovirus GII.4 by use of a challenge model involving humans. J Infect Dis (2012) 1.38
Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res (2011) 1.35
B7-H4 expression associates with cancer progression and predicts patient's survival in human esophageal squamous cell carcinoma. Cancer Immunol Immunother (2011) 1.34
Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS One (2011) 1.34
Functional analysis of the heat shock regulator HrcA of Chlamydia trachomatis. J Bacteriol (2002) 1.33
CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog (2012) 1.33
Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood (2005) 1.32
Crystallography of a Lewis-binding norovirus, elucidation of strain-specificity to the polymorphic human histo-blood group antigens. PLoS Pathog (2011) 1.31
PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood (2012) 1.30
Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia. Mol Microbiol (2003) 1.29
Detection of viral agents in fecal specimens of monkeys with diarrhea. J Med Primatol (2007) 1.29
High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma. Cancer (2004) 1.29
Extension of cortical synaptic development distinguishes humans from chimpanzees and macaques. Genome Res (2012) 1.27
The human immunodeficiency virus type 1 ribosomal frameshifting site is an invariant sequence determinant and an important target for antiviral therapy. J Virol (2004) 1.27
Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. J Infect Dis (2002) 1.26
Cryo-EM structure of a novel calicivirus, Tulane virus. PLoS One (2013) 1.26
Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control (2005) 1.25